《當(dāng)代藥物代謝》的目標(biāo)是涵蓋藥物代謝和處置的所有最新和突出的發(fā)展。該雜志的每一期都包含一系列及時(shí)深入的評(píng)論，這些評(píng)論由該領(lǐng)域的領(lǐng)導(dǎo)者撰寫，涵蓋了藥物代謝的一系列當(dāng)前主題。《當(dāng)代藥物代謝》是學(xué)術(shù)、臨床、政府和制藥科學(xué)家的重要期刊，他們希望了解最新和最重要的進(jìn)展。該雜志涵蓋以下領(lǐng)域：體外系統(tǒng)，包括cyp-450，酶誘導(dǎo)和抑制；藥物-藥物相互作用和酶動(dòng)力學(xué)；藥代動(dòng)力學(xué)/毒代動(dòng)力學(xué)/物種比例和外推；P-糖蛋白和轉(zhuǎn)運(yùn)載體；靶器官毒性和個(gè)體間變異性；藥物代謝和處置N研究；肝外代謝：第一階段和第二階段的新陳代謝。藥物代謝產(chǎn)物和加合物鑒定的最新進(jìn)展；藥物代謝產(chǎn)物和加合物的鑒定。

Current Drug Metabolism aims to cover all the latest and outstanding developments in drug metabolism and disposition. Each issue of the journal contains a series of timely in-depth reviews written by leaders in the field covering a range of current topics in drug metabolism. Current Drug Metabolism is an essential journal for academic, clinical, government and pharmaceutical scientists who wish to be kept informed and up-to-date with the latest and most important developments. The journal covers the following areas: In vitro systems including CYP-450, enzyme induction and inhibition; Drug-drug interactions and enzyme kinetics; Pharmacokinetics /toxicokinetics / species scaling and extrapolations; P-glycoprotein and transport carriers; Target organ toxicity and inter individual variability; Drug metabolism and disposition studies. Extrahepatic metabolism; Phase I and Phase II metabolism. Recent developments for the identification of drug metabolites and adducts. Identification of drug metabolites and adducts.